Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Like YpsoMate, this sustainability shift requires no regulatory changes, making it easy for pharmaceutical companies to integrate into existing treatment protocols
The platform's direct-pay model avoids insurance administrative hurdles
Efrain Santiago PharmD, MBA Disclaimer This information is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment
Presented for research literature review only Duan J et al
PMC 3062981
The SURMOUNT-5 trial showed Tirzepatide produced 20.2% average weight loss compared to 13.7% with Semaglutide over 72 weeks
US$ 24.06
US$ 23.26
US$ 25.64
US$ 25.13
US$ 22.66
